Table 2.
Results regarding definition and diagnosis of AD.
| Item | Consensus (%) | Discrepancy (%) |
|---|---|---|
| (i) AD can also develop de novo in adults or young adults, or even in advanced age | 93.6 | |
| (ii) AD is a multifaceted disease that is derived from the interactions of multiple factors, including the skin components (cellular and extracellular components that form the skin barrier) | 96.8 | |
| (iii) AD is a multifaceted disease that is derived from the interactions of multiple factors, including the immune system (innate and adaptative) | 97.6 | |
| (iv) AD is a multifaceted disease that is derived from the interactions of multiple factors, including the skin microbiome | 89.6 | |
| (v) AD is a multifaceted disease that is derived from the interactions of multiple factors, including genetic factors | 98.4 | |
| (vi) AD is a multifaceted disease that is derived from the interactions of multiple factors, including environmental factors | 98.4 | |
| (vii) Currently, the diagnosis and assessment of the severity of AD are made on clinical grounds | 97.6 | |
| (viii) The clinical criteria defined by Hanifin and Rajka are used for the clinical diagnosis of AD | 94.3 | |
| (ix) The clinical presentation of AD depends on the age of the patients | 92.8 | |
| (x) With greater frequency, children < 2 years of age and adults present involvement of the face and neck; in addition, adults also present involvement of the flexor and extensor surfaces | 94.3 | |
| (xi) Some forms of presentation seen in adults include dermatitis of the head and neck, chronic eczema of the hands, and multiple zones of lichenification or prurigo | 96.8 | |
| (xii) The classification of “intrinsic” AD (not associated with IgE) and “extrinsic” AD (associated with IgE) has practical implications related to specific avoidance strategies in the management of the disease | 60.0 | |
| (xiii) The blood eosinophil count is not a useful biomarker in AD | 37.1∗ | |
| (xiv) Currently there are no validated biomarkers that help in the diagnosis of AD | 83.2 |
AD: atopic dermatitis; IgE: immunoglobulin E. ∗37.1% of disagreement.